Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01807052 · ClinicalTrials.gov registry record
Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 34
- Enrollment target
NCT01807052 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 34 participants.
The verdict
NCT01807052 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
This trial studies biomarker expression in tissue samples from patients with bone sarcomas. Studying biomarker in tissue samples from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer
Interventions
- OTHER laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2009-11 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01807052
The ClinicalTrials.gov registry entry for NCT01807052 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT01807052 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01807052 about?
NCT01807052 is a clinical study titled "Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas". This trial studies biomarker expression in tissue samples from patients with bone sarcomas. Studying biomarker in tissue samples from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer
What is the current status of trial NCT01807052?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2009-11. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01807052?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01807052?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.